1. Home
  2. NVCR vs BKV Comparison

NVCR vs BKV Comparison

Compare NVCR & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • BKV
  • Stock Information
  • Founded
  • NVCR 2000
  • BKV 2015
  • Country
  • NVCR Switzerland
  • BKV United States
  • Employees
  • NVCR N/A
  • BKV N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • BKV Oil & Gas Production
  • Sector
  • NVCR Health Care
  • BKV Energy
  • Exchange
  • NVCR Nasdaq
  • BKV Nasdaq
  • Market Cap
  • NVCR 2.3B
  • BKV 2.1B
  • IPO Year
  • NVCR 2015
  • BKV 2024
  • Fundamental
  • Price
  • NVCR $22.09
  • BKV $23.31
  • Analyst Decision
  • NVCR Buy
  • BKV Strong Buy
  • Analyst Count
  • NVCR 5
  • BKV 8
  • Target Price
  • NVCR $33.40
  • BKV $28.38
  • AVG Volume (30 Days)
  • NVCR 741.8K
  • BKV 393.7K
  • Earning Date
  • NVCR 02-27-2025
  • BKV 02-26-2025
  • Dividend Yield
  • NVCR N/A
  • BKV N/A
  • EPS Growth
  • NVCR N/A
  • BKV N/A
  • EPS
  • NVCR N/A
  • BKV N/A
  • Revenue
  • NVCR $577,738,000.00
  • BKV $624,576,000.00
  • Revenue This Year
  • NVCR $19.97
  • BKV N/A
  • Revenue Next Year
  • NVCR $2.83
  • BKV N/A
  • P/E Ratio
  • NVCR N/A
  • BKV N/A
  • Revenue Growth
  • NVCR 14.63
  • BKV N/A
  • 52 Week Low
  • NVCR $11.70
  • BKV $17.39
  • 52 Week High
  • NVCR $34.13
  • BKV $26.78
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 36.77
  • BKV N/A
  • Support Level
  • NVCR $21.38
  • BKV N/A
  • Resistance Level
  • NVCR $22.95
  • BKV N/A
  • Average True Range (ATR)
  • NVCR 0.86
  • BKV 0.00
  • MACD
  • NVCR 0.01
  • BKV 0.00
  • Stochastic Oscillator
  • NVCR 34.25
  • BKV 0.00

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About BKV BKV Corporation Common Stock

BKV Corp is a growth-driven energy company. Its core business is to produce natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).

Share on Social Networks: